Second Sight Medical Raises $57.5M In Secondary Offering

Los Angeles-based biomedical products developer Second Sight Medical Products says it raised $57.5M in a public offering of 11,500,000 shares of its common stock. The publicly traded company, which trades on the NASDAQ as EYES, is developing implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals.